Statement of Principles concerning pterygium (Reasonable Hypothesis) (No. 116 of 2015)

Administered by Department of Veterans' Affairs

Legislation au F2015L01671 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 116 of 2015

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY STATEMENT

 

 

  1. The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), revokes Instrument No. 75 of 2007 determined under subsection 196B(2) of the VEA concerning pterygium.
  2. The Authority is of the view that there is sound medical-scientific evidence that indicates that pterygium and death from pterygium can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles concerning pterygium (Reasonable Hypothesis) (No. 116 of 2015).  This Instrument will in effect replace the revoked Statement of Principles.

Purpose and Operation

3.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

4.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting pterygium or death from pterygium, with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

5.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 31 October 2012 concerning pterygium in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

6.             The contents of this Instrument are in similar terms as the revoked Instrument.  Comparing this Instrument and the revoked Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'pterygium' in subsection 7(2);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);
  • new factor in subsection 9(3) concerning 'exposure of the affected eye to arc welding light';
  • new factor in subsection 9(4) concerning 'human papilloma virus type 16 or 18 infection of the conjunctiva';
  • removing the existing factor concerning 'solar UV exposure factor ratio' as sunlight exposure is covered by the factor in subsection 9(1) concerning 'sunlight exposure to the unprotected eye';
  • new definitions of 'MRCA' and 'VEA' in Schedule 1 - Dictionary;
  • revising the definitions of 'relevant service' and 'unprotected eye' in Schedule 1 - Dictionary; and
  • deleting the definitions of 'solar UV exposure factor ratio' and 'solar UV exposure factor ratio formula'.

Consultation

7.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to pterygium in the Government Notices Gazette of 31 October 2012, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

Human Rights

8.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

9.             The determining of this Instrument finalises the investigation in relation to pterygium as advertised in the Government Notices Gazette of 31 October 2012.

References

10.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 116 of 2015

Kind of Injury, Disease or Death: Pterygium

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors linking particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have pterygium;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting pterygium with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Statement;
  • replaces Instrument No. 75 of 2007; and
  • reflects developments in the available sound medical-scientific evidence concerning pterygium which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 116 of 2015, issued under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, addresses the problem of determining eligibility for benefits related to pterygium, a condition of the eye, for veterans and members of the Defence Force. This legislative instrument was enacted to ensure that the assessment and provision of benefits are based on sound medical-scientific evidence and aligns with the available evidence concerning pterygium. The instrument specifies the factors necessary to establish a reasonable hypothesis connecting pterygium or death from pterygium with certain types of military service, facilitating the claims process under the respective Acts. The Repatriation Medical Authority finalised the instrument after considering relevant evidence and conducting an investigation, as advertised in the Government Notices Gazette of 31 October 2012, and it promotes human rights by ensuring fair, proportionate, and transparent access to social security and healthcare benefits for eligible individuals.

Scope and Application

The Repatriation Medical Authority Instrument No. 116 of 2015, concerning pterygium, applies to veterans and current or former Defence Force members who are making or have made claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). It specifies the factors that must exist, and which factors must be related to various types of service, before a reasonable hypothesis can be raised that pterygium or death from pterygium is connected to the service rendered. The instrument facilitates the assessment of claims and the provision of compensation and medical treatment to eligible individuals, while also ensuring that the qualifying conditions for these benefits are reasonable, proportionate, and transparent. The instrument is compatible with human rights and does not derogate from any human rights; instead, it promotes various human rights including the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health. The instrument replaces the previously revoked Instrument No. 75 of 2007 and reflects the latest available sound medical-scientific evidence concerning pterygium.

Key Provisions

The Repatriation Medical Authority (the Authority) has revoked Instrument No. 75 of 2007 concerning pterygium under subsection 196B(8) of the Veterans' Entitlements Act 1986 (VEA), and has determined a new Statement of Principles (Reasonable Hypothesis) (No. 116 of 2015) pursuant to subsection 196B(2) of the VEA. This new instrument outlines the circumstances in which medical treatment and compensation can be extended to eligible persons who have pterygium, and replaces the revoked Statement of Principles. The purpose of this instrument is to facilitate claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA) by specifying the factors that must exist, and which of those factors must be related to particular kinds of service rendered by a person, before it can be said that a reasonable hypothesis has been raised connecting pterygium with the circumstances of that service (subsection 4). The obligations imposed on parties governed by this Act include the requirement that claimants must establish that they have pterygium and that the factors outlined in the Statement of Principles have occurred during their service (subsection 4). The Authority is also required to ensure that the determination of this instrument is based on the available sound medical-scientific evidence (subsection 5). The Authority must facilitate the review of decisions by the Veterans' Review Board and the Administrative Appeals Tribunal, and ensure that the rights of veterans, current and former Defence Force members and other persons such as their dependents are protected (subsection 3). Breach of the obligations imposed by this Act may result in civil or criminal consequences. The maximum penalties for offences under the VEA or the MRCA are not specified in the text, but may include fines or imprisonment depending on the nature and severity of the offence. The Authority may also face legal challenges if it is found to have failed to comply with its obligations under the Act. The compatibility of the instrument with human rights is affirmed in the Statement of Compatibility with Human Rights, which outlines how the instrument promotes the human rights of veterans, current and former Defence Force members and other persons such as their dependents.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Human Rights Law
Enforcement Powers

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.